The notices it replaced
- Reissues: PAR-15-165 NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
- 2 steps back: PAR-14-200 NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
- 3 steps back: PAR-11-219 NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
Replaced by PAR-18-594.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,239,790 in first-year total cost, median $968,794.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]8
- Special Emphasis Panel[ZAR1 KM (M2)]2
- Special Emphasis Panel[ZAR1 XZ (M1)]1
- Special Emphasis Panel[ZAR1 XZ (M2)]1
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL3
- CINCINNATI CHILDRENS HOSP MED CTR2
- CLEVELAND CLINIC LERNER COM-CWRU1
- DUKE UNIVERSITY1
- HELEN HAYES HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction1R01AR074131-01 | SPINDLER, KURT PAUL | CLEVELAND CLINIC LERNER COM-CWRU, OH | $1,363,577 | ZAR1 |
| 2018 | A Community-based Assessment of Skin Care, Allergies, and Eczema: The CASCADE Trial1R01AR071057-01A1 | SIMPSON, ERIC L | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $974,026 | AMSC |
| 2018 | Lupus Intervention Fatigue Trial (LIFT)1R01AR071091-01A1 | EHRLICH-JONES, LINDA S.RAMSEY-GOLDMAN, ROSALIND | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $344,288 | AMSC |
| 2017 | A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of ManNAc in Subjects with GNE Myopathy1U01AR070498-01A1 · under PAR-15-165 | AMATO, ANTHONY ARNOLDCARRILLO, NURIA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,897,534 | AMSC |
| 2017 | Multi-site Randomized Clinical Trial of FIT Teens for Juvenile Fibromyalgia1R01AR070474-01A1 · under PAR-15-165 | KASHIKAR-ZUCK, SUSMITA | CINCINNATI CHILDRENS HOSP MED CTR, OH | $1,766,426 | AMSC |
| 2017 | Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)1U01AR071077-01 · under PAR-15-165 | KARP, DAVID ROLSEN, NANCY J | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $1,443,698 | AMSC |
| 2017 | Treatment of Meniscal Problems in Osteoarthritis: TeMPO1U01AR071658-01 · under PAR-15-165 | KATZ, JEFFREY NEIL | BRIGHAM AND WOMEN'S HOSPITAL, MA | $797,762 | ZAR1 |
| 2017 | PTH (1-34) and Pelvic Fracture Healing: A Randomized Controlled Trial1U01AR069869-01A1 · under PAR-15-165 | NIEVES, JERI WANZOR | HELEN HAYES HOSPITAL, NY | $458,813 | AMSC |
| 2017 | A Phase I Study of the Safety of AAV2/8 LSPhGAA in Late-onset Pompe Disease1U01AR071693-01 · under PAR-15-165 | KOEBERL, DWIGHT D | DUKE UNIVERSITY, NC | $370,961 | AMSC |
| 2016 | Real-Time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality1U01AR067997-01A1 · under PAR-14-200 | MYER, GREGORY DONALD | CINCINNATI CHILDRENS HOSP MED CTR, OH | $698,292 | AMSC |
| 2015 | Weight Loss and Exercise for Communities with Arthritis in North Carolina (WE-CAN)1U01AR068658-01 · under PAR-14-200 | JORDAN, JOANNE M.MESSIER, STEPHEN P | WAKE FOREST UNIVERSITY, NC | $1,160,852 | ZAR1 |
| 2015 | Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL1U01AR068043-01A1 · under PAR-14-200 | BATHON, JOAN MARIESOLOMON, DANIEL HAL | BRIGHAM AND WOMEN'S HOSPITAL, MA | $963,561 | ZAR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.